期刊
JOURNAL OF VIROLOGY
卷 81, 期 9, 页码 4866-4871出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.02819-06
关键词
-
类别
资金
- NCI NIH HHS [CA 080192, R01 CA080192] Funding Source: Medline
- NIAID NIH HHS [HL/AI 078836] Funding Source: Medline
Intravenous (i.v.) delivery of recombinant adenovirus serotype 5 (AM) vectors for gene therapy is hindered by safety and efficacy problems. We have discovered a new pathway involved in unspecific Ad5 sequestration and degradation. After i.v. administration, Ad5 rapidly binds to circulating platelets, which causes their activation/aggregation and subsequent entrapment in liver sinusoids. Virus-platelet aggregates are taken up by Kupffer cells and degraded. Ad sequestration in organs can be reduced by platelet depletion prior to vector injection. Identification of this new sequestration mechanism and construction of vectors that avoid it could improve levels of target cell transduction at lower vector doses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据